Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piclidenoson in Knee Osteoarthritis
NCT00837291Phase 2Withdrawn
- Sponsor
- Can-Fite BioPharma Ltd.
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piclidenoson in osteoarthritis (OA), sponsored by Can-Fite BioPharma Ltd.. Planned start Nov 2018; status: withdrawn.
02
Drugs
piclidenoson
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00837291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837291.